SYNCRONEX



Trademark Coverage

No Class Specified

pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiopulmonary, genitourinary, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations

Owner

Glaxo Group Limited

Business in Greenford, GB

Owns 3786 trademarks

Timeline
  • Dec 20
    2013
    Cancelled SEC 8 (6 Yr)
  • May 12
    2010
    TEAS Change Of Correspondence Received
  • Oct 29
    2009
    Attorney Revoked And/Or Appointed
  • Oct 29
    2009
    TEAS Revoke/Appoint Attorney Received
  • May 15
    2007
    Registered Principal Register
  • Feb 27
    2007
    Published For Opposition
  • Feb 07
    2007
    Notice Of Publication
  • Jan 05
    2007
    Law Office Publication Review Completed
  • Jan 03
    2007
    Approved For PUB Principal Register
  • Dec 04
    2006
    TEAS/Email Correspondence Entered
  • Dec 04
    2006
    Correspondence Received In Law Office
  • Dec 04
    2006
    Assigned To LIE
  • Nov 13
    2006
    TEAS Response To Office Action Received
  • Nov 10
    2006
    TEAS Change Of Correspondence Received
  • May 25
    2006
    Inquiry To Suspension E Mailed
  • May 25
    2006
    Suspension Inquiry Written
  • May 17
    2006
    Assigned To Examiner
  • Apr 28
    2006
    LIE Checked SUSP To ATTY For Action
  • Aug 31
    2005
    Letter Of Suspension E Mailed
  • Aug 31
    2005
    Suspension Letter Written
  • Aug 31
    2005
    Assigned To Examiner
  • Feb 09
    2005
    New Application Entered In TRAM